Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Clinical Practice Guidelines for Hyperlipidemia: What Are the Recommendations?
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
Combination Therapies: Approaches for Getting to Goal Quickly vs Titration Over Time
MACE and SGLT2 Inhibitors: Do They Have an Impact?
MACE and SGLT2 Inhibitors: Do They Have an Impact?
Staging Coronary Risk: A New TRANSFORMative Approach
Staging Coronary Risk: A New TRANSFORMative Approach
TRANSFORM Trial: Overview and Potential Implications
TRANSFORM Trial: Overview and Potential Implications
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
Consensus Recommendations for Use of p16/Ki-67 Dual Staining Cytology in the Management of Individuals Testing Positive for HPV
ATTR-CM Management: Pearls From Recent Clinical Trials and Tailoring Therapy
ATTR-CM Management: Pearls From Recent Clinical Trials and Tailoring Therapy
ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
ACC 2024: What's Really New in Electrophysiology That Will Change My Practice?
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results